Clinical trial: FACTORS ASSOCIATED WITH URINARY INCONTINENCE AND EVALUATION OF PELVIC FLOOR MUSCLE ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS: CROSS-SECTIONAL STUDY

https://clinicaltrials.gov/study/NCT07489794?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20294

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Comparison of the Effects of Pelvic Floor Strengthening and Relaxation Exercises Delivered Via Telerehabilitation in Women Diagnosed With Multiple Sclerosis: A Randomized Controlled Study

https://clinicaltrials.gov/study/NCT07485556?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20275

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Chinese Patients With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07483450?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20262

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

​​What the EU Biotech Act delivers for Europe

Biotechnology drives cutting-edge medical innovation but is constrained by Europe’s fragmented regulatory landscape. The Biotech Act offers a critical opportunity to remove structural barriers, harmonize frameworks and accelerate patient access.

POLITICO

Clinical trial: A Phase 3 Study With an Open-Label Extension in Pediatric Participants to Evaluate the Safety, Efficacy, and Pharmacokinetics of Diroximel Fumarate and Dimethyl Fumarate for the Treatment of Relapsing Forms of Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07483632?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20263

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Assessment and Treatment of Behavior Problems in TSC at Preschool Age: A Telehealth Approach

https://clinicaltrials.gov/study/NCT06311474?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20252

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)

https://clinicaltrials.gov/study/NCT03816345?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20153

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology